Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-01

Clinical Trial Update: ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ACVDL treatment in newly diagnosed multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACVDL

Snippet

Sponsor: Vejle Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED